Aboriginal vascular health and insights into atherosclerosis
Crossref DOI link: https://doi.org/10.1038/jhh.2015.54
Published Online: 2015-05-28
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Stone, J A
Stone, J E
Text and Data Mining valid from 2015-05-28
Version of Record valid from 2015-05-28
Article History
First Online: 28 May 2015
Competing interests
: JAS has received speaking and Advisory Board honoraria from AMGEN, AstraZeneca, Boehringer-Ingelheim, Merck and Sanofi. JES declares no conflict of interest.